Opportunity
Alaska Online Public Notices #225596
Alaska Medicaid Drug Utilization Review Committee Public Meeting
Posted
October 20, 2026
Identifier
225596
The State of Alaska’s Drug Utilization Review Committee is holding a public meeting on Medicaid drug utilization and pharmacy topics; this is not a procurement opportunity. - Government buyer: State of Alaska, Department of Health, Division of Health Care Services, Pharmacy Services Unit. - Opportunity type: Public committee meeting; no products or services are being purchased, and no quantities, part numbers, or contract value are stated. - Agenda topics: Medicaid prescription and cost trends; medications and prior authorization, quantity-limit, and edit reviews; opioid-use trends; FDA and DEA updates; and FDA drug-safety and FAERS reports. - Named medications for review: Icotyde, Nereus, Trutakna, Hympavzi, Xolair, and Zurzuvae. - OEMs and vendors: No pharmaceutical manufacturers, vendors, or other companies are identified by name. Manufacturers may submit unsolicited clinical information related to agenda topics.
Description
The State of Alaska Department of Health, Division of Health Care Services, is announcing a public meeting of the Drug Utilization Review Committee. The meeting will be held by teleconference on November 20, 2026, at 1:00 p.m., and registration is required to join the webinar. Agenda topics include Medicaid prescription and cost trends, new and existing prior authorizations and quantity limits, opioid use trends, and FDA/DEA updates. Pharmaceutical manufacturers may submit unsolicited agenda-related material by November 6, 2026, and members of the public may submit material by November 18, 2026.